Immunotherapy treatment for liver cancer in Germany
Don't know where to start? Leave us a request, and the Booking Health team will arrange your trip for treatment in Germany, where you will improve the quality of life and health.
- Benefits of Immunotherapy for Liver Cancer Patients
- Types of Immunotherapy Used for Liver Cancer Treatment
- Leading Clinics and Experts for Liver Cancer Immunotherapy in Germany
Liver cancer remains one of the most severe and prognostically challenging oncological diseases. While traditional approaches like radiation therapy and chemotherapy show limited effectiveness, modern immunotherapy has revolutionized treatment outcomes at all stages. Particularly promising are dendritic cell vaccines, which create lasting anti-cancer immunity with minimal side effects. In this publication, we explore both standard and innovative immunotherapy treatments available in leading medical centers.
Benefits of Immunotherapy for Liver Cancer Patients
Hepatocellular carcinoma is an aggressive liver malignancy and the fourth leading cause of death from cancer in the world. More than 800,000 people die from this pathology every year.
The disease can be treated with surgery only at an early stage. But in 80% of cases, HCC liver cancer is detected beyond the stage one-three, when it is no longer possible to remove the tumor. Therefore, the five-year survival rate of patients with primary liver cancer is 15%, and the median survival rate, depending on the stage, is from 6 to 20 months.
Recent advances in immunotherapy have demonstrated promising results in improving the success rate of liver cancer treatment. Immunotherapy shows promising results in both early and advanced stages of liver cancer. Immunotherapy is considered a treatment method that should significantly increase patient survival rates. In addition, it is used after operations and minimally invasive procedures (ablation or chemoembolization) to reduce the risk of cancer recurrence.
Key benefits of immunotherapy for liver cancer patients include:
- Enhanced treatment options. Immunotherapy provides new hope for patients who cannot undergo surgery or have not responded to conventional treatments, offering an alternative therapeutic approach that works with the body's natural defenses.
- Reduced side effects. Compared to traditional chemotherapy, immunotherapy typically causes fewer and less severe side effects, allowing patients to maintain a better quality of life during treatment.
- Long-term protection. By training the immune system to recognize and attack cancer cells, immunotherapy can provide ongoing protection against cancer recurrence, potentially extending survival rates beyond traditional treatments.
- Combination potential. Immunotherapy can be effectively combined with other treatment methods, such as surgery or targeted therapy, to maximize therapeutic outcomes and improve overall treatment success.
Types of Immunotherapy Used for Liver Cancer Treatment
The field of immunotherapy has advanced significantly, making it possible to achieve long-term remission or cure several types of cancer, even at stage 4. In liver cancer treatment, immunotherapy methods are showing particularly promising results. Hundreds of clinical studies are now being conducted around the world aimed at assessing the effectiveness of various immunotherapy options for primary liver cancer.
Currently, two major types of immunotherapy have emerged as effective treatments for liver cancer: immune checkpoint inhibitors (ICIs) and therapeutic vaccines. Adoptive cell therapy, like CAR T-cell therapy and CIK immunotherapy, can also be used. Among these, dendritic cell-based vaccines represent a breakthrough in liver cancer immunotherapy. These vaccines are unique in their ability to create lasting anticancer immunity through a single outpatient procedure. Their exceptional tolerability and ability to maintain patients' quality of life, combined with their targeted immune-stimulating action, make them a particularly valuable treatment option. Additional immunotherapy approaches include oncolytic viruses and adoptive cell therapies.
The foundation for this revolutionary treatment approach was laid by Dr. Ralph Steinman, whose pioneering discovery of dendritic cells transformed our understanding of the immune system's role in fighting cancer. The significance of this breakthrough was recognized with the Nobel Prize in Medicine in 2011, marking a new era in cancer immunotherapy development.
Immune checkpoint inhibitors for liver cancer
The liver naturally maintains an immunotolerant environment to manage the constant flow of substances from the digestive system. This tolerance is achieved through various immunosuppressive molecules, including PD-L1, which protect against excessive inflammation. However, in liver cancer patients, increased expression of these molecules, particularly PD-1 and PD-L1, can lead to rapid disease progression by preventing the immune system from fighting the tumor.
Immune checkpoint inhibitors (ICIs) work by blocking these suppressive molecules, particularly PD-1 and PD-L1, enabling the immune system to better recognize and attack cancer cells. Six approved ICI drugs are currently available for liver cancer treatment, used either as first-line therapy for inoperable cases or as subsequent treatment options. Their effectiveness is often enhanced when combined with targeted therapies like bevacizumab.
While ICIs may not cure end-stage liver cancer, they can significantly extend life expectancy in responsive patients. Treatment involves intravenous infusions every 2-6 weeks and is generally well-tolerated, with manageable side effects such as elevated liver enzymes, fever, and occasional digestive symptoms.
Dendritic Cell Vaccines
While several types of cancer vaccines exist, dendritic cell-based vaccines have emerged as a groundbreaking advancement in liver cancer immunotherapy. These highly specialized vaccines harness the body's own immune system by using dendritic cells - the "commanders" of immune response that train other immune cells to recognize and attack cancer.
The treatment program consists of two outpatient visits:
Step 1 (Day 1):
- Initial consultation and clinical examination
- Laboratory assessments including complete blood count, liver and kidney function tests
- Collection of blood sample for individual vaccine manufacturing
Step 2 (Day 7):
- Administration of the individually manufactured LANEX-DC vaccine
- Supportive therapy and monitoring
- Consultation with specialists as needed
What makes dendritic cell vaccines particularly valuable for liver cancer patients:
- Personalized treatment using patient's own immune cells
- Single outpatient procedure without hospitalization requirement
- Minimal to no side effects, maintaining quality of life
- Development of lasting anti-cancer immunity after a single injection
- Compatibility with other treatments, enhancing overall therapeutic outcomes
To provide deeper insights into this innovative treatment approach, we interviewed Professor Frank Gansauge, a renowned expert in dendritic cell therapy with over 22 years of experience. Professor Gansauge has been at the forefront of implementing this Nobel Prize-winning treatment in clinical practice, achieving remarkable results in cancer treatment.
Leading Immunotherapy Expert Prof. Frank Gansauge: "Revolutionizing Cancer Care with Dendritic Cells"
Adoptive cell therapy
Adoptive cell therapy represents an innovative approach where immune cells are collected from the patient's blood, enhanced for their cancer-fighting properties, and reinfused. This includes several types of cells, such as natural killer cells, tumor-infiltrating lymphocytes (TIL), and cytokine-induced killer (CIK) cells.
CAR T-cell therapy, while still being evaluated for liver cancer, shows promising potential. Clinical studies have reported encouraging results, with one-year survival rates reaching 50.5% in advanced cases. Though only a subset of patients responds to this treatment, those who do may achieve long-term remission.
CIK immunotherapy has demonstrated particularly strong outcomes, especially for patients with larger tumors. Research spanning multiple clinical trials shows that CIK therapy can significantly reduce relapse risk and extend survival rates. When combined with treatments like chemoembolization and radiofrequency ablation, CIK therapy has nearly doubled patient survival time from 31 to 56 months.
Cost of Immunotherapy for Liver Cancer in Germany
The immunotherapy for liver cancer cost in Germany varies depending on the specific treatment approach and individual patient needs. While advanced cancer treatment requires significant investment, German clinics offer transparent pricing and comprehensive treatment programs that include all necessary diagnostic procedures, medications, and medical support.
| Treatment | 2-Year Survival Rate* | Response Rate** | Cost of treatment, €*** |
| Dendritic cell therapy | 60-85% | up to 90% | 20,000 - 38,000 |
| Checkpoint inhibitors | 35-45% | 35-45% | 375,000 - 420,000 for the full course |
| CAR T-cell therapy | 40-50% | 30-40% | 450,000 - 550,000 |
*Booking Health data. Survival rates vary widely depending on the type of cancer, the patient's condition, and specific circumstances.
**Booking Health data. Response rate is the number of patients who show improvement after treatment.
***The cost of treatment depends on the type of tumor, stage of cancer, and other factors.
Success Stories in Cancer Immunotherapy
Leading Clinics and Experts for Liver Cancer Immunotherapy in Germany
Germany offers world-class immunotherapy treatment for liver cancer at all stages. Here are the top specialized centers:
LDG Laboratories Dr. Gansauge Berg. Pioneers in LANEX-DC® dendritic cell immunotherapy with over 2,500 successful procedures. The clinic specializes in treating advanced-stage cancers, including liver malignancies, offering personalized dendritic cell-based vaccines with minimal side effects through outpatient care.
University Hospital Frankfurt am Main. A comprehensive cancer center combining innovative immunotherapy with cutting-edge treatments including CyberKnife technology. Their interdisciplinary tumor board ensures optimal treatment coordination for liver cancer patients.
Asklepios Hospital Barmbek Hamburg. An academic hospital featuring modern infrastructure and innovative approaches. Recognized by the German Cancer Society, it ranks among the top three worldwide medical tourism centers, treating over 110,000 patients annually.
Clinic of Advanced Biological Medicine Frankfurt. Specializes in integrative cancer treatment, combining traditional oncology with advanced biological therapies. Their 40-year expertise focuses on strengthening the immune system while managing treatment side effects.
Hyperthermia Center Hannover. Offers innovative cancer treatments combining immunotherapy with six different hyperthermia methods, providing comprehensive outpatient care without hospitalization.
Booking Health provides comprehensive support with advantages including:
- Selection of the most suitable hospital based on annual qualification profiles
- Direct communication with your chosen physician
- Advance medical program preparation without redundant examinations
- Cost savings up to 50% for international patients with no hidden fees
- Priority appointment scheduling on preferred dates
- Full treatment monitoring and support at all stages
- Assistance with medication purchase and delivery
- Post-treatment communication with the hospital
- Invoice control and refund of unused funds
- Coordination of additional examinations if needed
- Premium services including hotel booking, flights, and transfers
- Personal medical coordinator and interpreter throughout your stay
To start your treatment journey in Germany, contact Booking Health for professional assistance in organizing your medical care at these leading institutions.
Choose treatment abroad and you will for sure get the best results!
Authors:
The article was edited by medical experts, board certified doctors Dr. Nadezhda Ivanisova and Dr. Vadim Zhiliuk. For the treatment of the conditions referred to in the article, you must consult a doctor; the information in the article is not intended for self-medication!
Our editorial policy, which details our commitment to accuracy and transparency, is available here. Click this link to review our policies.
Sources:
Read:
Cancer immunotherapy in Germany
Treatment of stage 4 liver cancer in Germany
Dendritic cell therapy in cancer treatment in Germany - Vaccination against cancer
Adaptive Cell Therapy: CAR T-Cell Therapy
